Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Jinxi Zhao"'
Autor:
Qi Chen, Shu Huang, Huan Xu, Jieyu Peng, Ping Wang, Shiqi Li, Jinxi Zhao, Xiaomin Shi, Wei Zhang, Lei Shi, Yan Peng, Xiaowei Tang
Publikováno v:
Translational Psychiatry, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Mental disorders are the leading contributors to the globally nonfatal burden of disease. This study was aimed to estimate the burden of mental disorders in Asian countries. Based on GBD 2019, the prevalence and disability-adjusted life of y
Externí odkaz:
https://doaj.org/article/105fd81c30984eeba7eb4e87421a8ae4
Autor:
Yaofu Zhang, Li Jiang, Junheng Wang, Tongxin Wang, Chieh Chien, Weijun Huang, Xiaozhe Fu, Yonghua Xiao, Qiang Fu, Shidong Wang, Jinxi Zhao
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-23 (2022)
Abstract Objective To evaluate the cardiovascular and renal benefits of finerenone, sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagonlike peptide-1 receptor agonists (GLP-1 RA) in patients with Type 2 Diabetes Mellitus (T2DM) and chroni
Externí odkaz:
https://doaj.org/article/b1a70e3ccc0c4d3d8b3afc6667f3cace
Autor:
Yaofu Zhang, Junheng Wang, Li Jiang, Tongxin Wang, Zhuang Li, Xiaozhe Fu, Weijun Huang, Yonghua Xiao, Shidong Wang, Jinxi Zhao
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 14, Iss 1, Pp 1-13 (2022)
Abstract Objective To evaluate the efficacy and safety of finerenone and sodium-glucose cotransporter-2 inhibitors (SGLT2i) on reducing new-onset of atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease
Externí odkaz:
https://doaj.org/article/055e494e7410447884b913951ea85654
Autor:
Li Jiang, Qiang Fu, Shidong Wang, Yu Chen, Jiayue Li, Yonghua Xiao, Ruixi Sun, Esther Aijia Shen, Junheng Wang, Yaofu Zhang, Zhuang Li, Jiangteng Liu, Xiaozhe Fu, Yuanyuan Liu, Yu Zhao, Guanxun Su, Weijun Huang, Jinxi Zhao
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background Type 2 diabetes mellitus (T2DM) is a common metabolic disease with significant health, social, and economic consequences. Traditional Chinese medicine (TCM) could effectively regulate blood sugar and influence gut microbiota in T2
Externí odkaz:
https://doaj.org/article/355fb2b8975b4d2d8566beb3ac199a7d
DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma
Autor:
Fang Zhou, Lingfeng Zeng, Xi Chen, Fan Zhou, Zhen Zhang, Yixiao Yuan, Heping Wang, Huayi Yao, Jintao Tian, Xujie Liu, Jinxi Zhao, Xiaobin Huang, Jun Pu, William C. Cho, Jianxiong Cao, Xiulin Jiang
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Dual-specificity phosphatase 10 (DUSP10) correlates with inflammation, cytokine secretion, cell proliferation, survival, and apoptosis. However, its role in glioma is unclear. Herein, we sought to examine the expression and the underlying carcinogeni
Externí odkaz:
https://doaj.org/article/6c50d1cc1c3c4541b495a5b51556ad54
Autor:
Li Jiang, Shidong Wang, Jinxi Zhao, Chieh Chien, Yaofu Zhang, Guanxun Su, Xiaoyu Chen, Dechao Song, Yu Chen, Weijun Huang, Yonghua Xiao, Yandong Cao, Zixian Hu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: To compare the clinical efficacy and safety of SIX Traditional Chinese Patent Medicines (TCPM) recommended by guidelines in improving lipids for patients with prediabetes by network meta-analysis.Methods: Randomized controlled trials of 6
Externí odkaz:
https://doaj.org/article/bc2503fe7a8541cf88da67e8cdbd68ac
Autor:
Chao Liu, Xi Chen, Li Zhang, Jiaxiu Liu, Chunmei Li, Jinxi Zhao, Jun Pu, Peipei Tang, Bolin Liu, Xiaobin Huang
Publikováno v:
Journal of Neuropathology & Experimental Neurology. 81:511-521
Glioblastoma is a malignant CNS tumor with an extremely poor prognosis. F-box protein 11 (FBXO11) has E3 ubiquitin ligase activity and participates in the pathogenesis of multiple tumors but the role and mechanism of FBXO11 activity in glioblastoma r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1abaa06df07c117d71c6728857241891
https://doi.org/10.1093/jnen/nlac033
https://doi.org/10.1093/jnen/nlac033
Publikováno v:
Toxicon. 228:107094
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::835c05112ac16fdff66caf238efc76e9
https://doi.org/10.1016/j.toxicon.2023.107094
https://doi.org/10.1016/j.toxicon.2023.107094
Autor:
Li, Jiang, Yaofu, Zhang, Hua, Zhang, Yu, Chen, Weijun, Huang, Yonghua, Xiao, Esther, Aijia Shen, Zhuang, Li, Taiqi, Xue, Jinxi, Zhao, Shidong, Wang
Publikováno v:
Diabetes Research and Clinical Practice. 188:109878
To evaluate the efficacy of 6 Traditional Chinese patent medicines combined with lifestyle modification in the treatment of prediabetes with network meta-analysis.The randomized controlled trials (RCTs) of Shen qi jiang tang capsule/granule (Shenqi),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c6cbf674305ebe902cea39edec81fd0
https://doi.org/10.1016/j.diabres.2022.109878
https://doi.org/10.1016/j.diabres.2022.109878
Autor:
Li Jiang, Qiang Fu, Shidong Wang, Yu Chen, Jiayue Li, Yonghua Xiao, Ruixi Sun, Esther Aijia Shen, Junheng Wang, Yaofu Zhang, Zhuang Li, Jiangteng Liu, Xiaozhe Fu, Yuanyuan Liu, Yu Zhao, Guanxun Su, Weijun Huang, Jinxi Zhao
Publikováno v:
Trials. 23(1)
Background Type 2 diabetes mellitus (T2DM) is a common metabolic disease with significant health, social, and economic consequences. Traditional Chinese medicine (TCM) could effectively regulate blood sugar and influence gut microbiota in T2DM patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b0c587c5bc22a029f9c18a8dd6e89e
https://pubmed.ncbi.nlm.nih.gov/35422046
https://pubmed.ncbi.nlm.nih.gov/35422046